Quantinno Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Quantinno Capital Management's AXSM Position: Q3 2026 in Review
Quantinno Capital Management increased its Axsome Therapeutics (AXSM) stake by 27% in Q3 2026, buying an estimated $740K and bringing the position to 15,826 shares worth $2.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1871.
Quantinno Capital Management first reported a position in AXSM in Q2 2025 and has held it in 6 quarters since. The position peaked at $3.04M in Q2 2026. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Quantinno Capital Management held 15,826 shares of Axsome Therapeutics worth $2.92M as of Q3 2026.
- Quantinno Capital Management bought 3,401 Axsome Therapeutics shares in Q3 2026, an estimated $740K.
- Axsome Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1871 holding.
- Quantinno Capital Management first reported a position in Axsome Therapeutics in Q2 2025 and has held it in 6 quarters since.
- Quantinno Capital Management's Axsome Therapeutics position peaked at $3.04M in Q2 2026.
- 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.